Organon (OGN) has received FDA approval to expand the label of its birth control implant Nexplanon from its current three years to five years. Read more here.
The FDA extended the duration of use of Nexplanon for pregnancy prevention in women of reproductive potential for up to 5 years.
WASHINGTON (Circa) — A Circa investigation uncovered unsettling complications related to a popular birth control implant that's designed to prevent pregnancy for years. Nexplanon, a matchstick-sized ...
Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of ...
Just before the holidays, a patient was in my office for what I thought was going to be a routine appointment. After completing the exam, however, we started talking about what was really on her mind.